DrugDev and Citeline, part of Informa’s Pharma Intelligence vertical, announced the two companies integrated data from Citeline’s Trialtrove and Sitetrove intelligence platforms with the DrugDev Spark unified clinical operations suite. Indexing information captured by Citeline on more than 390,000 investigators across over 265,000 trials in more than 170 countries to the industry-standard DrugDev Golden Number adds significantly to the amount of information available for study planning and site identification through DrugDev Spark.
By incorporating data from Citeline into DrugDev Spark, mutual Citeline and DrugDev biopharma clients can now identify the ideal sites at which to conduct their clinical trials. Additionally, clients using DrugDev Spark will be able to move from study planning and site identification to other proven solutions such as site activation, site payments, eConsent, learning management, document exchange, and site engagement.
The collaboration allows Informa’s Pharma Intelligence vertical’s clients who subscribe to both Trialtrove and Sitetrove system via XML feed and who are also clients of DrugDev to access a broader range of data sources. By integrating Citeline data components into the DrugDev Spark study planning and site identification toolset, users can simplify the task of having to utilize multiple resources to research clinical trial investigators at high performing sites for their own clinical studies.
Citeline clients participating in the Investigator Databank or TransCelerate’s Investigator Registry collaboration, for example, will now have the ability to see data from: online profiles, their own CTMS, other member’s CTMS, the DrugDev network, clinicaltrials.gov, and Citeline’s Trialtrove and Sitetrove.
“We are excited to be working with DrugDev for our mutual clients’ benefit in improving the speed and success of clinical drug development,” Linda Blackerby, President of Informa Pharma Intelligence said. “Our customers need data, together with technology, to deliver new and innovative drugs into the pharmaceutical market. We look forward to furthering the relationship with DrugDev to assist our customers in achieving that goal.”
“Informa has a reputation for excellence in pharma intelligence among the global pharma community. We are excited to partner with Informa because we are committed to making it easier and more expedient for pharma and biotech organizations to conduct more clinical trials,” Elisa Cascade, President, Data Solutions at DrugDev said. “By integrating data in one trusted location, we can now simplify the evidence-based planning and site identification process for our customers through access to a single integrated view of data from all available sources – enabling sponsors to make better site selection decisions, faster.”